1. Pink Sheet
  3. >>US FDA Performance Tracker

J&J Offers Sliding Timeframe for Covid Boosters Based on Individual Patient and Geographic Need

 
• By Sarah Karlin-Smith

Johnson and Johnson’s one-shot Covid vaccine gets a solid efficacy boost with second shot administered two months after primary vaccination, but the company will argue based on much more limited data that a longer window between shots may be preferable for some populations.  

J&J Janssen sign
J&J’s COVID-19 booster application heads to the FDA’s VRBPAC on 15 October • Source: Alamy

Johnson & Johnson is seeking US Food and Drug Administration authorization for a booster dose of its COVID-19 vaccine that could be given between two and more than six months after the first dose depending on the burden of the virus in a particular region and an individual’s circumstances such as occupation and health status.

The company says booster timing should depend on the epidemiologic profile of the virus in the region and “perhaps most important,” the benefit/risk assessment for individuals, according to briefing...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from US FDA Performance Tracker

More from Regulatory Trackers